Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.
Margalit O, Harmsen WS, Shacham-Shmueli E, Voss MM, Boursi B, Wagner AD, Cohen R, Olswold CL, Saltz LB, Goldstein DA, Hurwitz H, Tebbutt NC, Kabbinavar FF, Adams RA, Chibaudel B, Grothey A, Yoshino T, Zalcberg J, de Gramont A, Shi Q, Lenz HJ. Margalit O, et al. Among authors: voss mm. Eur J Cancer. 2023 Nov;194:113339. doi: 10.1016/j.ejca.2023.113339. Epub 2023 Sep 28. Eur J Cancer. 2023. PMID: 37813779 No abstract available.
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.
Margalit O, Harmsen WS, Shacham-Shmueli E, Voss MM, Boursi B, Wagner AD, Cohen R, Olswold CL, Saltz LB, Goldstein DA, Hurwitz H, Tebbutt NC, Kabbinavar FF, Adams RA, Chibaudel B, Grothey A, Yoshino T, Zalcberg J, de Gramont A, Shi Q, Lenz HJ. Margalit O, et al. Among authors: voss mm. Eur J Cancer. 2023 Jan;178:162-170. doi: 10.1016/j.ejca.2022.10.022. Epub 2022 Nov 2. Eur J Cancer. 2023. PMID: 36446161 Free article.
CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
Lozada ME, Zhang N, Jin W, Wongjarupong N, Yang JD, Voss MM, Prasai K, Amakye DO, Harmsen WS, Chaudhary S, Bathe OF, Borad MJ, Patel TC, Gores GJ, Therneau TM, Roberts LR. Lozada ME, et al. Among authors: voss mm. Am J Gastroenterol. 2023 Dec 1;118(12):2173-2183. doi: 10.14309/ajg.0000000000002258. Epub 2023 Mar 20. Am J Gastroenterol. 2023. PMID: 36940423 Free PMC article.
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy.
Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Laughlin BS, et al. Among authors: voss mm. Adv Radiat Oncol. 2022 Dec 10;8(2):101143. doi: 10.1016/j.adro.2022.101143. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36845611 Free PMC article.
Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite Practice.
Buras MR, Breen WG, Laack NN, Gross TV, Zaniletti I, Leavitt T, Golafshar MA, Voss MM, Mahajan A, Keole SR, Ahmed SK, Ulbrich A, Daniels TB, DeWees TA. Buras MR, et al. Among authors: voss mm. Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):472-477. doi: 10.1016/j.ijrobp.2022.06.091. Epub 2022 Jul 15. Int J Radiat Oncol Biol Phys. 2022. PMID: 35840115
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Thorpe CS, DeWees TA, Laughlin BS, Vallow LA, Seneviratne D, Pockaj BA, Cronin PA, Halyard MY, Vern-Gross TZ, McGee LA, McLaughlin SA, Voss MM, Golafshar MA, Bulman GF, Vargas CE. Thorpe CS, et al. Among authors: voss mm. Adv Radiat Oncol. 2022 Oct 21;8(1):101111. doi: 10.1016/j.adro.2022.101111. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36483068 Free PMC article.
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, Liu W, Schild SE, Merrell KW, Sio TT. Yu NY, et al. Among authors: voss mm. Clin Lung Cancer. 2022 Dec;23(8):e526-e535. doi: 10.1016/j.cllc.2022.07.017. Epub 2022 Aug 10. Clin Lung Cancer. 2022. PMID: 36104272 Free article.
16 results